Skip to main content

Table 3 Characteristics of the included studies for estimating the diagnostic accuracy of the Gail model

From: Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis

Ref

Author

Publication year

Geographic background

Study design

Gail model version

Sample size

Mean age (years)

Study population

Time period

TP

FP

FN

TN

[11]

Rockhill

2001

America

Cohort

2

82,109

45–71

Nurses’ Health Study (NHS)

1992–1997

596

27,457

758

53,298

[25]

Weik

2005

America

Cross-sectional

2

543

20–80

Women who underwent a stereotactic or ultrasound-guided breast biopsy examination

2001–2003

58

95

81

309

[26]

Adams-Campbell-1

2007

America

Nested case–control

1

1450

21–69

Black Women’s Health Study (BWHS)

1995–2003

130

102

595

623

[26]

Adams-Campbell-2

2007

America

Nested case–control

3

1450

21–69

Black Women’s Health Study (BWHS)

1995–2003

30

19

695

706

[31]

Chlebowski

2007

America

Cohort

2

64,568

63

Predicted ER-positive breast cancer in Women’s Health Initiative (WHI) study

1993–2005

462

22,276

461

41,369

[15]

Tice

2008

America

Cohort

2

629,229

40–74

National Cancer Institute-funded Breast Cancer Surveillance Consortium (BCSC)

Since1994

2442

103,852

6342

516,593

[47]

Li

2009

China

Case–control

2

420

40–75

Bao’an Maternal and Child Health Care Hospital, Shenzhen

2003–2008

98

20

5

297

[44]

Wang

2010

China

Case–control

1

228

56

Breast cancer and controls in Shenzhou Hospital of Shenyang Medical College

1998–2007

65

10

4

149

[37]

Ulusoy

2010

Turkey

Case–control

2

1290

49.49

Breast cancer and controls in Ankara University School of Medicine

2002–2008

87

51

563

589

[33]

Buron

2013

Spain

Cohort

2

2200

49–64

Participants with a positive screening mammogram in “Parc de Salut Mar” breast cancer screening program

1996–2010

24

449

28

1161

[48]

Zhou

2014

China

Case–control

1

280

48.62

Breast cancer and controls in Huangpu District in Shanghai of China

2010

72

11

71

126

[45]

Duan

2014

China

Case–control

2

400

52.58

Breast cancer and controls in the First Affiliated Hospital of KunMing Medical University

2007–2011

24

7

176

193

[49]

Huang

2015

China

Case–control

1

317

54.1

Breast cancer and controls in Guangxi Maternal and Child Health Care Hospital

2012–2014

116

13

41

147

[50]

An

2016

China

Case–control

2

567

> 40

Breast cancer and controls in China Japan Union Hospital of Jilin University

2011–2015

207

105

93

162

  1. Note: Gail model type 1, original Gail model; Gail model type 2, modified Gail model for Caucasian-American; Gail model type 3, modified Gail model for African-American
  2. TP true positive, FP false positive, FN false negative, TN true negative, ER estrogen receptor